Decibel Therapeutics Inc.

(NASDAQ:DBTX) Trade

By |

Equities News

Company chart and information is provided by TradingView based on 15-minute-delayed data.


Profile

Decibel Therapeutics Inc is a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments for hearing and balance disorders. It aims to restore and improve hearing and balance through the restoration and regeneration of functional hair cells and non-sensory support cells within the inner ear.

Contact Information

Website: www.decibeltx.com
Main Phone: +1 617 370-8701
Address: 1325 Boylston Street
Address 2: Suite 500
State: MA
City / Town: Boston
Country: US
Postal Code: 02215

Issuer Information

Exchange: NGS
CEO: Laurence E. Reid
Employees: 37
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)(541714)

Equities News

(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange N/A